These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11133116)

  • 1. Setting of a colorimetric method to determine the viability of Trypanosoma cruzi epimastigotes.
    Muelas-Serrano S; Nogal-Ruiz JJ; Gómez-Barrio A
    Parasitol Res; 2000 Dec; 86(12):999-1002. PubMed ID: 11133116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of resazurin microtiter assay for drug sensibility testing of Trypanosoma cruzi epimastigotes.
    Rolón M; Vega C; Escario JA; Gómez-Barrio A
    Parasitol Res; 2006 Jul; 99(2):103-7. PubMed ID: 16506080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buthionine sulfoximine increases the toxicity of nifurtimox and benznidazole to Trypanosoma cruzi.
    Faundez M; Pino L; Letelier P; Ortiz C; López R; Seguel C; Ferreira J; Pavani M; Morello A; Maya JD
    Antimicrob Agents Chemother; 2005 Jan; 49(1):126-30. PubMed ID: 15616285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new pharmacological screening assay with Trypanosoma cruzi epimastigotes expressing beta-galactosidase.
    Vega C; Rolón M; Martínez-Fernández AR; Escario JA; Gómez-Barrio A
    Parasitol Res; 2005 Mar; 95(4):296-8. PubMed ID: 15682334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of anti-Trypanosoma cruzi compounds on HSP60 levels.
    Muelas-Serrano S; Pérez-Serrano J; Gómez-Barrio A; Ochoa C; Martínez J; Rodríguez-Caabeiro F
    Parasitol Res; 2001 Aug; 87(8):615-8. PubMed ID: 11510996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of nifurtimox, benznidazole, and beta-lapachone on the metabolism of DNA, RNA and proteins in Trypanosoma cruzi].
    Goijman SG; Stoppani AO
    Rev Argent Microbiol; 1983; 15(4):193-204. PubMed ID: 6086046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole.
    Luna KP; Hernández IP; Rueda CM; Zorro MM; Croft SL; Escobar P
    Biomedica; 2009 Sep; 29(3):448-55. PubMed ID: 20436996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of buthionine sulfoximine nifurtimox and benznidazole upon trypanothione and metallothionein proteins in Trypanosoma cruzi.
    Maya JD; Rodríguez A; Pino L; Pabón A; Ferreira J; Pavani M; Repetto Y; Morello A
    Biol Res; 2004; 37(1):61-9. PubMed ID: 15174306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural alterations induced by nifurtimox and another nitro derivative on epimastigotes of Trypanosoma cruzi.
    Muelas-Serrano S; Pérez-Serrano J; Gómez-Barrio A; Arán VJ; Rodríguez-Caabeiro F
    Parasitol Res; 2002 Feb; 88(2):97-101. PubMed ID: 11936510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
    Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
    Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological characterization of Trypanosoma cruzi strains.
    Martínez-Díaz RA; Escario JA; Nogal-Ruiz JJ; Gómez-Barrio A
    Mem Inst Oswaldo Cruz; 2001 Jan; 96(1):53-9. PubMed ID: 11285475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of glutathione in the susceptibility of Trypanosoma cruzi to drugs.
    Moncada C; Repetto Y; Aldunate J; Letelier ME; Morello A
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 94(1):87-91. PubMed ID: 2576749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving in vitro screening compounds anti-Trypanosoma cruzi by GFP-expressing parasites.
    Delvoss CMM; Inoue AH; da Silva RV; Fragoso SP; Eger I
    Mem Inst Oswaldo Cruz; 2024; 119():e230223. PubMed ID: 38716979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Introduction of changes in the DNA of Trypanosoma cruzi by trypanocidal agents].
    Goijman SG; Frasch AC; Stoppani AO
    Rev Argent Microbiol; 1984; 16(2):75-86. PubMed ID: 6400724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural sesquiterpene lactones induce programmed cell death in Trypanosoma cruzi: a new therapeutic target?
    Jimenez V; Kemmerling U; Paredes R; Maya JD; Sosa MA; Galanti N
    Phytomedicine; 2014 Sep; 21(11):1411-8. PubMed ID: 25022207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Damage of Trypanosoma cruzi deoxyribonucleic acid by nitroheterocyclic drugs.
    Goijman SG; Frasch AC; Stoppani AO
    Biochem Pharmacol; 1985 May; 34(9):1457-61. PubMed ID: 3888226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of natural and synthetic polygodial derivatives against
    Turner DN; Just J; Dasari R; Smith JA; Bissember AC; Kornienko A; Rogelj S
    Nat Prod Res; 2021 Mar; 35(5):792-795. PubMed ID: 31032640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological characterization of a beta-galactosidase expressing clone of Trypanosoma cruzi CL strain.
    Le-Senne A; Muelas-Serrano S; Fernández-Portillo C; Escario JA; Gómez-Barrio A
    Mem Inst Oswaldo Cruz; 2002 Dec; 97(8):1101-5. PubMed ID: 12563473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility to benznidazole, nifurtimox and posaconazole of Trypanosoma cruzi isolates from Paraguay.
    Acosta N; Yaluff G; López E; Bobadilla C; Ramírez A; Fernández I; Escobar P
    Biomedica; 2020 Dec; 40(4):749-763. PubMed ID: 33275352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of trypanocidal drugs on protein biosynthesis in vitro and in vivo by Trypanosoma cruzi.
    Gonzalez NS; Cazzulo JJ
    Biochem Pharmacol; 1989 Sep; 38(17):2873-7. PubMed ID: 2673249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.